Adeno-associated virus (AAV) vectors have emerged as invaluable tools in gene therapy, offering a promising avenue for treating various genetic disorders. However, with their increasing application, concerns regarding toxicity and safety have become paramount. Evaluating AAV vector toxicity and safety is critical to ensuring the efficacy and reliability of gene therapy treatments. The...